5 results match your criteria perimegaprosthetic infection

  • Page 1 of 1

Combined Techniques of Non-invasive Tc-Besilesomab/Tc-Sulfur Colloid with Hybrid SPECT/CT Imaging in Characterising Cellulitis from Symptomatic Perimegaprosthetic Infection: A Case Report.

Malays Orthop J 2020 Nov;14(3):188-193

Department of Nuclear Medicine, Radiotherapy and Oncology, Universiti Sains Malaysia, Kubang Kerian, Malaysia.

Megaprosthesis is used to restore the form and function of massive skeletal defects, but it is accompanied by risks of failure, mainly due to perimegaprosthetic infection (PMI). In practice, the diagnosis of infected megaprosthesis among patients with a high index of clinical suspicion, elevated serological markers, and multiple negative or inconclusive imaging can be very challenging and poses a diagnostic conundrum to many orthopaedic surgeons. We present the case of a symptomatic 26-year-old female with large B-cell lymphoma who developed cellulitis with suspected complication of PMI 15 months post-implantation. Read More

View Article and Full-Text PDF
November 2020

Modular Endoprostheses for Nonneoplastic Conditions: Midterm Complications and Survival.

Biomed Res Int 2016 5;2016:2606521. Epub 2016 Dec 5.

Department of Orthopaedic and Trauma Surgery, University of Pisa, Pisa, Italy.

The use of modular endoprostheses is a viable option to manage both tumor resection and severe bone loss due to nonneoplastic conditions such as fracture sequelae, failed osteoarticular grafts, arthroplasty revisions, and periprosthetic fractures. We sought to investigate both midterm complications and failures occurred in 87 patients who underwent a megaprosthetic reconstruction in a nonneoplastic setting. After a mean follow-up of 58 (1-167) months, overall failure-free survival was 91. Read More

View Article and Full-Text PDF
February 2017

Risk Factors for Perimegaprosthetic Infections After Tumor Resection.

Orthopedics 2017 Jan 7;40(1):e11-e16. Epub 2016 Dec 7.

Periprosthetic joint infection remains one of the most challenging and pervasive complications following megaprosthetic replacement after tumor resection. The authors conducted a systematic review of the literature for clinical studies that reported a risk factor analysis for perimegaprosthetic joint infections. The search included English-language studies published up to July 2015. Read More

View Article and Full-Text PDF
January 2017

Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature.

Arch Orthop Trauma Surg 2017 Feb 25;137(2):149-153. Epub 2016 Oct 25.

Department for Orthopaedics und Trauma Surgery, Rheinische Friedrich-Wilhelms-University Bonn, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany.

Purpose And Objective: Bone resection regarding adequate surgical margins is the treatment of choice for malignant bone tumors. In the case of metastasis-related complications, so-called skeletal-related events, it is highly important to achieve pain relief and a stable joint situation to re-mobilize the patients immediately following surgery. To bridge the often large osseous defect zones after tumor resection, both cemented and uncemented modular endoprosthetic systems are widely used. Read More

View Article and Full-Text PDF
February 2017

Treatment solutions are unclear for perimegaprosthetic infections.

Clin Orthop Relat Res 2013 Oct;471(10):3204-13

Department of Orthopaedics, University of Pittsburgh, 3471 Fifth Avenue, Pittsburgh, PA, 15213, USA,

Background: Infection about a megaprosthesis is a dreaded complication. Treatment options vary from d├ębridement alone to staged revisions, arthrodesis, and amputation. Indications for how to treat this complication are unclear. Read More

View Article and Full-Text PDF
October 2013
  • Page 1 of 1